Fluorescent Kinase Probes Enabling Identification and Dynamic Imaging of HER2(+) Cells

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• The Epidermal Growth Factor Receptor (EGFR/ERBB/HER) family, particularly ERBB2 (HER2), is crucial in cancer signaling and a target for therapies like trastuzumab and lapatinib.
• Accurate identification and classification of cancer cells are vital for selecting effective treatment strategies.
• Current methods may not fully capture the dynamic activation state of receptor tyrosine kinases.

Discussion:

• Novel kinase probes targeting the ERBB2 (HER2) intracellular ATP-binding pocket are developed.
• These probes exhibit a turn-on fluorescent response upon binding, enabling differentiation of ERBB2-positive from ERBB2-negative cells.
• The probe's signal intensity correlates with the phosphotyrosine-dependent activation state of ERBB2.

Key Insights:

• The probes demonstrate high specificity for ERBB2, mimicking therapeutic inhibitors.
• They are compatible with live-cell imaging, allowing visualization of ERBB2 activity in real-time.
• Probe signal reflects both ERBB2 expression levels and its activation status.

Outlook:

• These probes provide complementary information to traditional immunohistochemical assays.
• The ability to monitor dynamic changes in ERBB2 activation offers new avenues for understanding treatment response.
• Potential applications in guiding personalized cancer treatment and drug development.